# BIO-EMS Complete Audit and Master Execution Order — 11 September 2026

**Status:** Authoritative current audit  
**Audit baseline:** `main@af9a69963d091eda6a16bee17f69a94d912136d6`  
**Source version:** `0.20.0`  
**Latest published source release:** `v0.20.0`

## 1. Executive conclusion

BIO-EMS source software is substantially mature, but Pilot readiness is not yet closed. The correct continuation is to stabilize the Pilot delivery path before implementing the final commercial protection/device-PKI layer.

The immediate controlled order is:

1. COM-01 through COM-06 — Admin-managed Communication Channels source implementation.
2. Build a new controlled internal Pilot Setup containing the current source plus COM changes.
3. Repeat clean-machine installer qualification on more than one Windows 10/11 x64 target.
4. Execute Pilot hardware integration and bench qualification.
5. Complete live notification/failover evidence required for the Pilot.
6. Execute BIO EGYPT field installation, calibration, commissioning and customer acceptance.
7. Stabilize defects discovered during real Pilot operation.
8. Only after Pilot software/hardware stability: execute the deferred final device-trust/commercial-protection work and production-signing/release gates.

The approved Device Trust / replaceable-host architecture remains authoritative, but it is deliberately **deferred from the immediate Pilot sequence**. Architecture approval must not be confused with deployed implementation.

## 2. Repository / CI baseline

- Current authoritative `main`: `af9a69963d091eda6a16bee17f69a94d912136d6`.
- PR #205 merged the approved Communication Channel Administration plan.
- Latest full CI evidence on the tested PR head:
  - Backend: typecheck, build, lint, format and **114 test files / 809 tests passed**.
  - Frontend: typecheck, lint, format, build and **52 test files / 299 tests passed**.
- Current source version remains `0.20.0`; no new source release is declared by this audit.

## 3. Completed / established source areas

The following are treated as established source baselines unless a later defect specifically reopens them:

- P0-P7 source/product closure.
- P8-02 through P8-08 installation provisioning/RBAC source closure.
- Global Arabic/English localization and RTL/LTR behavior.
- UI/UX refresh UX-01 through UX-09.
- Dashboard/Monitored Areas/Live Board telemetry refresh behavior.
- Alarm acknowledgment/recovery correction.
- Email and Telegram live Critical Alarm delivery evidence.
- Existing recipient directory, escalation policy and durable notification delivery architecture.
- Licensing source packages LIC-01 through LIC-13 as previously merged source work.
- DEP-01-01 through DEP-01-05 source implementation.
- Internal Windows Setup build pipeline and signed internal Pilot packaging introduced through PRs #199-#203.

These completion statements do not imply field acceptance, production release, commercial protection qualification or customer sign-off.

## 4. Installer status after PRs #199-#203

Repository history after the 8 September handoff materially changed the installer position:

- PR #199 added repeatable Windows GitHub Actions generation of the single Setup artifact.
- PR #200 added build-scoped internal Authenticode signing for the BIO EGYPT Pilot artifact.
- PR #201 added a one-click elevated Pilot launcher with certificate installation and signature validation.
- PR #202 added automatic installation diagnostics/logging.
- PR #203 fixed the clean-device failure path where service installation could be skipped after certificate-path failure/partial installation.

Therefore old wording that DEP-01 implementation or signing “has not started” is obsolete.

Still open:
- successful post-PR-203 clean-machine execution evidence;
- proof that all three BIO-EMS Windows services install and recover after reboot;
- integrated HTTPS/frontend/API health;
- Repair/Upgrade/rollback evidence;
- retained-data Uninstall evidence;
- repeated qualification on more than one clean Windows computer;
- public/commercial Authenticode signing decision;
- final production installer publication.

## 5. Notification status

### Proven

- Email provider source exists and live delivery evidence passed.
- Telegram provider source exists and live delivery evidence passed.
- Recipients and Escalation Policies are configurable from the application.
- Durable delivery evidence exists.

### Open

- COM-01 through COM-07 Communication Channel Administration.
- Meta WhatsApp live provider acceptance remains externally blocked.
- Live SMS/GSM evidence remains open.
- The Pilot may continue using Telegram as the accepted interim online messaging channel while WhatsApp remains blocked.
- Provider credential changes currently must not be represented as fully Admin-managed until COM implementation is merged and accepted.

## 6. COM work package — immediate software priority

Authority:
`docs/project-management/COMMUNICATION-CHANNEL-ADMIN-CONFIG-WORK-PACKAGE-2026-09-11.md`.

Execution:

- **COM-01** secure configuration domain/storage.
- **COM-02** RBAC-protected redacted API.
- **COM-03** runtime integration for Email/Telegram/WhatsApp/SMS-GSM.
- **COM-04** bilingual `Configuration -> Communication Channels` UI.
- **COM-05** safe Test actions/diagnostics.
- **COM-06** configurable channel priority/failover plus regression.
- **COM-07** Pilot acceptance evidence.

COM-01 through COM-06 are source work. COM-07 closes only after real Pilot evidence.

## 7. Pilot installer qualification — next after COM source

After COM-01 through COM-06 merge:

1. Produce a fresh controlled internal signed Pilot Setup from authoritative `main`.
2. Verify Setup checksum and Authenticode evidence.
3. Run Fresh Install on clean Windows 10/11 x64.
4. Verify:
   - BIOEMS-MQTT;
   - BIOEMS-InfluxDB;
   - BIOEMS-Backend;
   - port exposure;
   - HTTPS landing/application;
   - API health;
   - persistent configuration and data paths.
5. Reboot and verify automatic recovery.
6. Exercise Repair.
7. Exercise Upgrade/rollback using a controlled prior build.
8. Exercise retained-data Uninstall.
9. Repeat the qualification on at least one additional computer to detect machine-specific assumptions.
10. Record machine/build/checksum/evidence without provider secrets.

Do not qualify on the development workstation when an unrelated Mosquitto service is present.

## 8. Hardware / controller execution track

After the Setup baseline is repeatable:

1. Freeze the Pilot controller hardware BOM.
2. Assemble Standard Pilot controller path and any selected Advanced comparison hardware.
3. Validate sensor accuracy and wiring protection.
4. Validate ESP32/device registration and Site/Area/Sensor mapping using the current Pilot-safe mechanism.
5. Validate MQTT telemetry, reconnect and local buffering/replay.
6. Validate power-loss/restart recovery.
7. Validate Alarm generation against real Sensor values.
8. Validate Telegram/Email Alarm delivery.
9. Validate the selected SMS/GSM fallback path.
10. Execute endurance/72-hour gate where applicable.
11. Capture calibration and hardware evidence.

The deferred production Device PKI/Secure Boot/Flash Encryption architecture must not block early Pilot hardware validation unless required for a specific safety test.

## 9. BIO EGYPT field Pilot gate

Pilot remains **NOT COMMISSIONED / NOT ACCEPTED** until field evidence exists.

Required:
- physical installation;
- final Site/Area/Sensor mapping;
- calibration records;
- communications checks;
- Alarm challenge tests;
- notification recipient/escalation verification;
- reboot/power/network interruption tests;
- technical commissioning;
- customer ADMIN acceptance/UAT;
- defect resolution and acceptance evidence.

## 10. Deferred final security/protection track

Approved architecture:
- `docs/BIO-EMS-SITE-BOUND-LICENSING-ARCHITECTURE.md`;
- `docs/security/device-registration.md`;
- `docs/security/activation-workflow.md`.

Immediate implementation is deferred until the Pilot Setup, hardware and field workflow are stable.

Later execution:
- DEV-TRUST-01 through DEV-TRUST-11;
- production device certificates/mTLS;
- ESP32 secure key storage/Secure Boot/Flash Encryption as selected;
- final host-transfer/recovery behavior;
- commercial activation and anti-copy qualification;
- production signing-key operations;
- public/commercial Authenticode decision;
- final Production Installer qualification.

This sequencing avoids repeatedly reissuing/reworking machine-bound protection while the Pilot is still being moved between test computers.

## 11. Documentation audit findings

### Critical stale documentation

- `README.md` contained stale installer statements and corrupted encoding sequences.
- `PROJECT_STATE.md` did not reflect PRs #199-#205 comprehensively.
- `IMPLEMENTATION_PLAN.md` still contained ordering from before the installer/security decisions.
- `docs/deployment/FULL-OFFLINE-WINDOWS-INSTALLER-PLAN.md` understated actual installer progress.
- `PILOT_SCOPE.md` was empty.
- `RISK_REGISTER.md` was empty.

### Historical documents

Historical Sprint/P/BF/UX closure records remain historical evidence. They should not be rewritten merely to mirror current status. When they conflict with this audit, the authority order is:

1. `PROJECT_STATE.md`
2. `IMPLEMENTATION_PLAN.md`
3. this audit
4. current work-package authority document
5. historical closure/handoff documents

## 12. Version / release decision

Keep `VERSION`, backend package version and release manifest at `0.20.0` until a deliberate next-release decision.

The frontend package's internal `0.0.0` package metadata is not the product source-version authority.

No new GitHub Release or production-ready declaration should be made solely because this documentation audit merges.

## 13. Definition of Pilot-ready

BIO-EMS Pilot is ready for controlled customer deployment only when:

- COM source and acceptance are sufficient for Pilot operation;
- internal Setup installs repeatably on clean target computers;
- required services/HTTPS/reboot lifecycle pass;
- selected hardware passes bench validation;
- Email/Telegram and required SMS fallback evidence pass;
- Site configuration/calibration/commissioning evidence exists;
- no open Severity-1 Pilot blocker remains.

Commercial-production readiness is a later gate and additionally requires deferred security/protection and production-signing qualification.
